|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 207.28 USD | -0.56% |
|
-0.52% | +18.27% |
| 08-03 | Mizuho Adjusts Price Target on Biogen to $241 From $221 | MT |
| 07-30 | BMO Capital Adjusts Price Target on Biogen to $208 From $196, Maintains Market Perform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 30.8B | |||||
| 75.96B | |||||
| 49.03B | |||||
| 47.88B | |||||
| 43.39B | - | ||||
| 24.45B |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
